Feed / VERX

Vertex, Inc.

VERX

Technology · 11.99 +1.7% today

Isolated · not yet confirmedMarket checked 2 Oct, 13:40 GMT-4

Market read

No connected market move is active around Vertex, Inc..

No new filing conclusion is available. 0 of 0 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 17 directly disclosed connections are confirming.

Company+1.7% todayVolume comparison unavailable
Market groupNo active group readNo durable group available
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Reported 10.9% ($16.4M) growth in software subscription revenue attributed in part to price increases and cross-selling to existing customers.

Invalidation: The isolated read changes if VERX's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Technology · Software - Application

No new filing conclusion is available. 0 of 0 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 17 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • Reported 10.9% ($16.4M) growth in software subscription revenue attributed in part to price increases and cross-selling to existing customers.

Company research

Understand the business, not just the ticker

As of Oct 2, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods8
Price observations342
Usable filing statements129
Verified relationships13
Evidence supporting the case
  • Latest annual revenue changed +12.2% year over year.
  • Net margin changed +8.9 percentage points in the latest annual period.
  • Operating cash flow covered net income at 22.96x in the latest annual period.
  • Pricing and mix has repeated favorable evidence across 4 filings.
Evidence challenging the case

No qualifying adverse evidence was identified; that is not proof there is no downside.

Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Oct 1, 2026

12.31
6m+1.8%12m-50.4%24m—
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$425.5M+13.6%——
2022-12-31$491.6M+15.5%——
2023-12-31$572.4M+16.4%——
2024-12-31$666.8M+16.5%——
2025-12-31$748.4M+12.2%——

What management says matters

Persistent and emerging business drivers

Credit and interest ratesnegative · 4 filings
“Interest expense will vary as a result of fluctuations in the level of debt outstanding as well as interest rates on such debt.”
10-Q · May 7, 2026 ↗
Legal and regulatory exposurepositive · 4 filings
“This increase in research and development expenses was primarily due to an increase in personnel costs related to development work associated with new solutions to address end-to-end data analysis and compliance needs of our customers, and continued expansion…”
10-Q · May 7, 2026 ↗
Pricing and mixpositive · 4 filings
“The increase was primarily driven by $32.9 million of growth in revenues from existing customers through their expanded use of our solutions as well as price increases, and $36.2 million in growth of subscriptions of our solutions to new customers.”
10-Q · May 7, 2026 ↗
Product pipeline and R&Dnegative · 4 filings
“For further information refer to Note 15, “ Restructuring” to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.”
10-Q · May 7, 2026 ↗

Valuation discipline

Descriptive valuation snapshot

Price/sales — · EV/sales —. Comparisons use only industry-matched filing peers.

Scenario scaffold

No usable price/earnings or price/sales multiple (need a fresh price).

Price action

How the market is pricing the story

11.99+1.7% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 2 Oct, 13:40 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for VERX. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for VERX. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind VERX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

CRMSalesforce, Inc.partnerMay 7, 2026 ▾

“These partners include Adobe/Magento, Coupa, Kintsugi AI, Inc., Microsoft Dynamics, NetSuite, Oracle, Salesforce, SAP, SAP Ariba, Shopify, Workday and Zuora.”

MSFTMicrosoft CorporationpartnerMay 7, 2026 ▾

“These partners include Adobe/Magento, Coupa, Kintsugi AI, Inc., Microsoft Dynamics, NetSuite, Oracle, Salesforce, SAP, SAP Ariba, Shopify, Workday and Zuora.”

Depended on by

CRSPCRISPR Therapeutics AGpartnerMay 4, 2026 ▾

“CASGEVY is the first therapy to emerge from our strategic partnership with Vertex and is being advanced under a joint development and commercialization agreement between us and Vertex and certain of its affiliates.”

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 14 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

VERX is currently a Follower in the organic co-movement group Unknown Theme. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for VERX; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.